Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03102021 · ClinicalTrials.gov registry record · Phase 2
The Effect of Human Recombinant Erythropoietin in Acute Renal Failure
A Phase 2 study, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT03102021: Completed Phase 2 study, sponsored by North Texas Veterans Healthcare System.
NCT03102021 is a Phase 2 study that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 25 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03102021, a Phase 2 study, has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of erythropoietin when used in high dose during acute kidney injury can decrease the number of days of kidney injury.
Interventions
- DRUG saline
- DRUG erythropoietin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
What the finished NCT03102021 record still lists
NCT03102021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT03102021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03102021 about?
NCT03102021 is a clinical study titled "The Effect of Human Recombinant Erythropoietin in Acute Renal Failure". The purpose of this study is to determine if the use of erythropoietin when used in high dose during acute kidney injury can decrease the number of days of kidney injury.
What is the current status of trial NCT03102021?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2006-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT03102021?
The interventions under investigation include: saline (DRUG), erythropoietin (DRUG).
Who is sponsoring clinical trial NCT03102021?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03102021's enrollment target sits among peer trials
25 1719th of 2000 higher than 245 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia